EC 1.1.1.63 - 17β- hydroxysteroid:NAD ⁺ 17- oxidoreductase (testosterone 17\xCE\xB2- dehydrogenase)

3D structures of EC 1.1.1.63 - testosterone 17\xCE\xB2-dehydrogenase in Protein Data Bank

updated: 6 January 2022, 2:15

1. 3r43: AKR1C3 Complexed with Mefenamic Acid
2. 3r58: AKR1C3 Complex with Naproxen
3. 4dbs: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) in Complex with Nadp+ and 3-[4 -(nitronaphthalen-1-amino)) Benzoic Acid
4. 4dbu: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) in Complex with Nadp+ and 3-((4 -(trifluoromethyl)phenyl) Amino)benzoic Acid
5. 3uwe: AKR1C3 Complexed with 3-phenoxybenzoic Acid
6. 3r6i: AKR1C3 Complex with Meclofenamic Acid
7. 3r7m: AKR1C3 Complex with Sulindac
8. 3r8g: AKR1C3 Complex with Ibuprofen
9. 3r8h: AKR1C3 Complex with Zomepirac
10. 3r94: AKR1C3 Complex with Flurbiprofen
11. 3ufy: AKR1C3 Complex with R-naproxen
12. 3ug8: AKR1C3 Complex with Indomethacin at Ph 7.5
13. 3ugr: AKR1C3 Complex with Indomethacin at Ph 6.8
14. 4fa3: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with (r)-1-(naphthalen-2-ylsulfonyl)piperidine-3- Carboxylic Acid (86)
15. 4fal: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with 3-((3,4-dihydroisoquinolin-2(1h)-yl)sulfonyl)-n- Methylbenzamide (80)
16. 4fam: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with 3-((3,4-dihydroisoquinolin-2(1h)-yl)sulfonyl)benzoic Acid (17)
17. 4dbw: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) in Complex with Nadp+ and 2'-desmethyl-indomethacin
18. 4dz5: W227F Active Site Mutant of AKR1C3
19. 4h7c: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with 1-{4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl}-2- Pyrrolidinone
20. 4hmn: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with (4-(4-chlorophenyl)piperazin-1-yl)(morpholino) Methanone (24)